CA2452257A1 - Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 - Google Patents
Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 Download PDFInfo
- Publication number
- CA2452257A1 CA2452257A1 CA002452257A CA2452257A CA2452257A1 CA 2452257 A1 CA2452257 A1 CA 2452257A1 CA 002452257 A CA002452257 A CA 002452257A CA 2452257 A CA2452257 A CA 2452257A CA 2452257 A1 CA2452257 A1 CA 2452257A1
- Authority
- CA
- Canada
- Prior art keywords
- pharmaceutical formulation
- moiety
- organocyclic
- group
- uea1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30282201P | 2001-07-02 | 2001-07-02 | |
| US60/302,822 | 2001-07-02 | ||
| US30286801P | 2001-07-03 | 2001-07-03 | |
| US60/302,868 | 2001-07-03 | ||
| PCT/US2002/020948 WO2003004062A1 (en) | 2001-07-02 | 2002-07-02 | Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2452257A1 true CA2452257A1 (en) | 2003-01-16 |
Family
ID=26973111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002452257A Abandoned CA2452257A1 (en) | 2001-07-02 | 2002-07-02 | Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7166296B2 (enExample) |
| EP (1) | EP1404372B1 (enExample) |
| JP (1) | JP2004536109A (enExample) |
| AT (1) | ATE459376T1 (enExample) |
| CA (1) | CA2452257A1 (enExample) |
| DE (1) | DE60235549D1 (enExample) |
| WO (1) | WO2003004062A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| WO2007052641A1 (ja) * | 2005-11-01 | 2007-05-10 | Kumamoto University | 腸管免疫賦活剤 |
| KR101138312B1 (ko) | 2009-04-13 | 2012-04-27 | 주식회사 바이오에프디엔씨 | 펩타이드 유도체 및 그를 포함하는 화장료 조성물 |
| WO2012156376A1 (en) | 2011-05-13 | 2012-11-22 | Merrion Pharmaceuticals Ireland Ltd. | Use of plant lectins to target leukocytes |
-
2002
- 2002-07-02 CA CA002452257A patent/CA2452257A1/en not_active Abandoned
- 2002-07-02 JP JP2003510071A patent/JP2004536109A/ja active Pending
- 2002-07-02 US US10/187,550 patent/US7166296B2/en not_active Expired - Fee Related
- 2002-07-02 DE DE60235549T patent/DE60235549D1/de not_active Expired - Fee Related
- 2002-07-02 AT AT02761028T patent/ATE459376T1/de not_active IP Right Cessation
- 2002-07-02 EP EP02761028A patent/EP1404372B1/en not_active Expired - Lifetime
- 2002-07-02 WO PCT/US2002/020948 patent/WO2003004062A1/en not_active Ceased
-
2006
- 2006-06-20 US US11/425,237 patent/US20060276628A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1404372A1 (en) | 2004-04-07 |
| US20060276628A1 (en) | 2006-12-07 |
| JP2004536109A (ja) | 2004-12-02 |
| US7166296B2 (en) | 2007-01-23 |
| WO2003004062A9 (en) | 2003-04-10 |
| DE60235549D1 (de) | 2010-04-15 |
| ATE459376T1 (de) | 2010-03-15 |
| US20040062796A1 (en) | 2004-04-01 |
| WO2003004062A1 (en) | 2003-01-16 |
| EP1404372B1 (en) | 2010-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Guler et al. | Encapsulation of pyrene within self-assembled peptide amphiphile nanofibers | |
| US8653238B2 (en) | Compositions and methods for transport of molecules with enhanced release properties across biological barriers | |
| JP5211109B2 (ja) | 膜転位剤および製薬学的有効成分の複合物 | |
| ES2209948T3 (es) | Formulacion de un peptico de liberacion sostenida. | |
| JP2000509394A (ja) | 細胞膜を横切って物質を輸送するためのポリペプチド結合体 | |
| CN106421806A (zh) | 一种逐级响应纳米自组装树枝状前药及制备方法和应用 | |
| US12390421B2 (en) | Zwitterionic dendritic amphiphiles, zwitterionic dendrimers, zwitterionic telodendrimers, nanocarriers comprising same, and methods of making and using same | |
| CN113292635B (zh) | 靶向cd47的多肽及其应用 | |
| KR20100014255A (ko) | 항바이러스성 제제로서 자기 조립성 양친매성 폴리머 | |
| WO2013025347A1 (en) | Compact multifunctional ligand to enhance colloidal stability of nanoparticles | |
| JP2014524477A (ja) | ペプチドナノ粒子およびその使用 | |
| CN104906076A (zh) | 程序化多重靶向的树状大分子组装体药物递送系统及其制备方法和应用 | |
| CN108164584A (zh) | Vap多肽及其在制备靶向诊疗肿瘤药物中的应用 | |
| US20090238886A1 (en) | Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods | |
| EP1404372B1 (en) | Pharmaceutical formulations and ligands for use therein; mimetics for uea-1 | |
| KR102156649B1 (ko) | 효소 반응 양친매성 펩티드를 포함하는 약물전달 시스템 | |
| US9114082B2 (en) | Nanoparticle peptide compositions | |
| TR201723077A2 (tr) | Ultrases duyarli manyeti̇k hedefli̇ nano i̇laç taşiyici si̇stem | |
| EP3952912B1 (en) | Cell-penetrating conjugate systems | |
| CN115232195B (zh) | 寡肽二维纳米材料及其应用 | |
| KR100905627B1 (ko) | 활성제 전달 시스템 및 활성제의 보호 및 투여 방법 | |
| NZ622045B2 (en) | Peptide nanoparticles and uses thereof | |
| CZ2000731A3 (cs) | Zesítěné částice vhodné pro aplikaci farmaceutického prostředku, způsob jejich výroby, farmaceutický prostředek, který je obsahuje a způsob jeho výroby |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |